ARDENT HEALTH PARTNERS INC Stock Price, News & Analysis

Ardent Health (NYSE: ARDT) has appointed Chris Schoeplein as its new chief development officer to spearhead the company's strategic growth initiatives. Schoeplein, who previously served as senior vice president at Kaufman Hall's mergers and acquisitions practice, brings nearly two decades of healthcare strategy and development experience to the role.

In his new position, Schoeplein will be responsible for leading development efforts across Ardent's existing markets and supporting expansion into new regions. His key responsibilities include driving growth in inpatient and outpatient care settings through acquisitions, partnerships, and joint ventures, while also overseeing due diligence, market intelligence, and integration planning.

The appointment comes at what CEO Marty Bonick describes as a "pivotal time" in Ardent's growth journey, as the company aims to scale its consumer-centric platform and extend its joint venture model.

Ardent Health (NYSE: ARDT) reported strong Q1 2025 financial results with total revenue of $1.50 billion, up 4.0% year-over-year. The company achieved net income of $41 million ($0.29 per diluted share) and Adjusted EBITDA of $98 million, growing 2.5% Y/Y. Key operational highlights include a 7.6% increase in admissions and 2.7% growth in adjusted admissions, driven by strong inpatient volumes and heightened flu season. Inpatient surgeries grew 3.4%, while total surgeries declined slightly by 0.7%. The company maintains a solid balance sheet with $495 million in cash and $1.1 billion in total debt. Ardent Health reaffirmed its 2025 guidance, projecting total revenue of $6.2-6.45 billion and Adjusted EBITDA of $575-615 million.

Ardent Health (NYSE: ARDT), a healthcare provider focused on mid-sized urban communities across the U.S., has announced its participation in two major investor conferences in May 2025:

• Bank of America Securities 2025 Health Care Conference in Las Vegas (May 13-14), featuring a presentation on May 14 at 11:40 a.m. ET
• 2025 RBC Capital Markets Global Healthcare Conference in New York City (May 20), including a fireside chat at 8:00 a.m. ET

Live audio webcasts will be available on Ardent Health's investor relations website with 90-day replay access. Management will also conduct one-on-one meetings with registered investors at both conferences.

Ardent Health (NYSE: ARDT) announced that seven of its facilities earned an "A" Hospital Safety Grade from The Leapfrog Group for spring 2025. The recognition is based on over 30 measures of safety, including errors, accidents, injuries, and infections. Notably, 81% of Ardent's eligible facilities earned an "A" or "B" grade, significantly outperforming the national average of 56%. The seven facilities earning "A" grades include hospitals in New Jersey, Oklahoma, New Mexico, and Texas. The Leapfrog Hospital Safety Grade is the only hospital ratings program focused exclusively on preventable medical errors and safety measures, with grades updated biannually.

Ardent Health (NYSE: ARDT) has scheduled its first quarter 2025 financial results announcement for Tuesday, May 6, 2025, after market close. The company will host a conference call and webcast on Wednesday, May 7, 2025, at 10:00 a.m. ET to discuss the results and conduct a Q&A session.

The webcast and presentation materials will be accessible through the Investor Relations section at ir.ardenthealth.com. Participants are advised to register 15 minutes before the scheduled start time. The teleconference replay will be available until May 21, 2025.

Ardent Health (NYSE: ARDT) has announced key leadership changes, appointing Dave Caspers as chief operating officer to oversee operations across 30 hospitals and 280 sites of care in six states. Caspers, formerly vice president of omnichannel operations at Walmart Health, brings extensive experience in retail healthcare and health system operations.

The company also announced three senior leadership promotions: Anika Gardenhire elevated to chief digital and transformation officer, Rebecca Kirkham promoted to senior vice president and chief communications and corporate affairs officer, and Reed Smith elevated to senior vice president and chief consumer officer.

In his new role, Caspers will focus on executing strategic growth initiatives, driving operational excellence, and optimizing the company's consumer-centric operating model across markets.

Ardent Health (NYSE: ARDT) reported strong Q4 2024 results, with total revenue growing 19.3% year-over-year to $1,606 million. The quarter was positively impacted by the New Mexico state directed payment program approval and recovery from a 2023 cybersecurity incident.

Key Q4 2024 metrics include:

• Net income of $114 million ($0.81 per diluted share) vs. net loss of $4 million in Q4 2023
• Adjusted EBITDA increased 213% to $183 million
• Admissions up 11.5% with strong growth in general medicine, cardiology and neurology
• Surgeries increased 6.3% year-over-year

For full-year 2024, revenue increased 10.3% to $5.97 billion, with Adjusted EBITDA growing 58.4% to $498 million. The company maintained strong liquidity with $557 million in cash and total debt of $1.1 billion. In January 2025, ARDT acquired 18 urgent care clinics from NextCare Urgent Care in New Mexico and Oklahoma.

Ardent Health (NYSE: ARDT), a leading healthcare provider in mid-sized urban communities across the U.S., announced participation in upcoming investor conferences.

The company will attend the Leerink Partners Global Healthcare Conference on Monday, March 10, 2025, in Miami, Florida. Ardent Health's management team will engage in a fireside chat at 8 a.m. ET.

Additionally, they will join the KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, 2025, with a fireside chat scheduled for 9 a.m. ET.

A live audio webcast of these presentations will be accessible on the company's Investor Relations website at https://ir.ardenthealth.com, with replays available for 90 days.

Ardent Health's management will also be available for one-on-one meetings with registered investors at each conference. For further details, investors can contact their sales representative at the host firm or reach out to Dave Styblo, Ardent Health's senior vice president of investor relations, at Investor.Relations@ardenthealth.com.

TruLite Health, developer of health equity solutions, has expanded its leadership team with key appointments. Walter D. Conwell, MD, MBA, former chief diversity officer at Morehouse School of Medicine, has been appointed as president. The company also added two board members: Edmondo Robinson, MD, MBA, a digital health leader and Ardent Health Services board member, and Caleb DesRosiers, JD, MPA, a pharmaceutical executive.

TruLite's main product, Truity™, is software that integrates with electronic health records to address clinical bias at the point of care. The solution uses explainable AI and machine learning to drive patient-specific clinical, social, and behavioral interventions, aiming to improve healthcare outcomes and costs. The software aligns with regulatory requirements from the Joint Commission, CMS, and FDA.